Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2019 Filed Jan 3, 2020 21:23 UTC |
Walker Kathryn ADirector
|
Disposition to issuerCommon Stock | 0.44 | $9.89 | $4.35 |
DisclosureSEC source: 0001773229-20-000004 · primary_doc.xml · nonDerivative · entry 2 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,818 F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:23 UTC |
Walker Kathryn ADirector
|
Exercise / conversionCommon Stock | 250.44 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773229-20-000004 · primary_doc.xml · nonDerivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,818.44 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 03, 2019 Filed Mar 17, 2020 19:29 UTC |
McCray Gregory JamesDirector
|
GrantCommon Stock | 71.78 | $9.01 | $646.56 |
DisclosureSEC source: 0001773229-20-000023 · primary_doc.xml · nonDerivative · entry 6 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,979.829 F1 · security: Reflects 322.068 shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 09:58 UTC |
NICHOLS ROY JDirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000037 · primary_doc.xml · derivative · entry 1 NICHOLS ROY J · CIK 0000937725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 20:06 UTC |
Foliano MichaelChief Financial Officer
|
GrantPhantom Stock · Derivative | 167.742 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000046 · primary_doc.xml · derivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,910.893 Underlying: Common Stock · 167.742 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 17:34 UTC |
STANTON THOMAS RDirector · CEO
|
GrantPhantom Stock · Derivative | 942.058 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000044 · primary_doc.xml · derivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,195.543 Underlying: Common Stock · 942.058 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 19:42 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 194.837 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000045 · primary_doc.xml · derivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,281.095 Underlying: Common Stock · 194.837 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 16:29 UTC |
McCray Gregory JamesDirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000043 · primary_doc.xml · derivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 15:57 UTC |
Melone Anthony J.Director
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000041 · primary_doc.xml · derivative · entry 1 Melone Anthony J. · CIK 0001507363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 16:16 UTC |
Jacqueline Hourigan RiceDirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000042 · primary_doc.xml · derivative · entry 1 Jacqueline Hourigan Rice · CIK 0001637150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 15:17 UTC |
Nair BalanDirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000039 · primary_doc.xml · derivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 15:35 UTC |
Walker Kathryn ADirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000040 · primary_doc.xml · derivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 15:10 UTC |
HUSS H FENWICKDirector
|
GrantDividend Equivalent Rights · Derivative | 82.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000038 · primary_doc.xml · derivative · entry 1 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250.44 Underlying: Common Stock · 82.447 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| November 25, 2019 Filed Nov 25, 2019 18:01 UTC |
Kimpe MarcSVP, Research & Development
|
PurchaseCommon Stock | 3,000 | $9.02 | $27,060.00 |
DisclosureSEC source: 0001773229-19-000035 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,155 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:01 UTC |
Harris RayChief Information Officer
|
GrantCommon Stock | 9,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000025 · primary_doc.xml · nonDerivative · entry 1 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,081 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 18:57 UTC |
Centis RonaldSVP, Operations
|
GrantCommon Stock | 11,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000023 · primary_doc.xml · nonDerivative · entry 1 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,919 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 20:18 UTC |
Scheiterer EduardSVP, Research & Development
|
GrantCommon Stock | 10,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000024 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,953 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:27 UTC |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 14,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000022 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,139 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:05 UTC |
STANTON THOMAS RDirector · CEO
|
GrantCommon Stock | 66,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000020 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,124 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 17:17 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 14,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000021 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,610 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 22:13 UTC |
McInnis Jeffrey FSVP, Subscriber Solutions
|
GrantCommon Stock | 9,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000028 · primary_doc.xml · nonDerivative · entry 1 McInnis Jeffrey F · CIK 0001773229 · SVP, Subscriber Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,880 F1 · security: Represents restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 20:08 UTC |
Kimpe MarcSVP, Research & Development
|
GrantCommon Stock | 9,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000026 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,280 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 12, 2019 Filed Nov 20, 2019 20:12 UTC |
Kimpe MarcSVP, Research & Development
|
Disposition to issuerCommon Stock | 875 | $9.72 | $8,505.00 |
DisclosureSEC source: 0001773229-19-000033 · primary_doc.xml · nonDerivative · entry 3 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,155 Read SEC document |
| November 12, 2019 Filed Nov 20, 2019 19:47 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 399 | $9.72 | $3,878.28 |
DisclosureSEC source: 0001773229-19-000032 · primary_doc.xml · nonDerivative · entry 3 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,668 Read SEC document |
| November 12, 2019 Filed Nov 20, 2019 19:18 UTC |
STANTON THOMAS RDirector · CEO
|
Tax withholdingCommon Stock | 2,133 | $9.72 | $20,732.76 |
DisclosureSEC source: 0001773229-19-000029 · primary_doc.xml · nonDerivative · entry 3 STANTON THOMAS R · CIK 0001191219 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,858 Read SEC document |
| November 12, 2019 Filed Nov 20, 2019 19:35 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 374 | $9.72 | $3,635.28 |
DisclosureSEC source: 0001773229-19-000031 · primary_doc.xml · nonDerivative · entry 3 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,927 Read SEC document |
| November 12, 2019 Filed Nov 20, 2019 19:27 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 475 | $9.72 | $4,617.00 |
DisclosureSEC source: 0001773229-19-000030 · primary_doc.xml · nonDerivative · entry 3 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,030 Read SEC document |
| November 11, 2019 Filed Nov 20, 2019 20:12 UTC |
Kimpe MarcSVP, Research & Development
|
Disposition to issuerCommon Stock | 875 | $9.65 | $8,443.75 |
DisclosureSEC source: 0001773229-19-000033 · primary_doc.xml · nonDerivative · entry 2 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,030 Read SEC document |
| November 11, 2019 Filed Nov 20, 2019 19:47 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 346 | $9.65 | $3,338.90 |
DisclosureSEC source: 0001773229-19-000032 · primary_doc.xml · nonDerivative · entry 2 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,067 Read SEC document |
| November 11, 2019 Filed Nov 20, 2019 19:18 UTC |
STANTON THOMAS RDirector · CEO
|
Tax withholdingCommon Stock | 2,003 | $9.65 | $19,328.95 |
DisclosureSEC source: 0001773229-19-000029 · primary_doc.xml · nonDerivative · entry 2 STANTON THOMAS R · CIK 0001191219 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,991 Read SEC document |
| November 11, 2019 Filed Nov 20, 2019 19:35 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 327 | $9.65 | $3,155.55 |
DisclosureSEC source: 0001773229-19-000031 · primary_doc.xml · nonDerivative · entry 2 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,301 Read SEC document |
| November 11, 2019 Filed Nov 20, 2019 19:27 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 431 | $9.65 | $4,159.15 |
DisclosureSEC source: 0001773229-19-000030 · primary_doc.xml · nonDerivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,505 Read SEC document |
| November 09, 2019 Filed Nov 20, 2019 20:12 UTC |
Kimpe MarcSVP, Research & Development
|
Disposition to issuerCommon Stock | 1,375 | $9.63 | $13,241.25 |
DisclosureSEC source: 0001773229-19-000033 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,905 Read SEC document |
| November 09, 2019 Filed Nov 20, 2019 19:47 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 540 | $9.63 | $5,200.20 |
DisclosureSEC source: 0001773229-19-000032 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,413 Read SEC document |
| November 09, 2019 Filed Nov 20, 2019 19:18 UTC |
STANTON THOMAS RDirector · CEO
|
Tax withholdingCommon Stock | 3,130 | $9.63 | $30,141.90 |
DisclosureSEC source: 0001773229-19-000029 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,994 Read SEC document |
| November 09, 2019 Filed Nov 20, 2019 19:35 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 511 | $9.63 | $4,920.93 |
DisclosureSEC source: 0001773229-19-000031 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,628 Read SEC document |
| November 09, 2019 Filed Nov 20, 2019 19:27 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 674 | $9.63 | $6,490.62 |
DisclosureSEC source: 0001773229-19-000030 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,936 Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 19:21 UTC |
Nair BalanDirector
|
PurchaseCommon Stock | 10,000 | $9.19 | $91,883.00 |
DisclosureSEC source: 0001773229-19-000019 · primary_doc.xml · nonDerivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,505 Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 14:08 UTC |
Shannon Roger DVP of Treas & Corp Development
|
SaleCommon Stock | 6,200 | $9.71 | $60,227.42 |
DisclosureSEC source: 0001773229-19-000018 · primary_doc.xml · nonDerivative · entry 1 Shannon Roger D · CIK 0001370527 · VP of Treas & Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,809 Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 14:52 UTC |
Whalen Daniel TChief Product Officer
|
GrantCommon Stock | 9,700 | $8.81 | $85,457.00 |
DisclosureSEC source: 0001770330-19-000015 · primary_doc.xml · nonDerivative · entry 1 Whalen Daniel T · CIK 0001689876 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,700 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| August 16, 2019 Filed Mar 17, 2020 19:29 UTC |
McCray Gregory JamesDirector
|
GrantCommon Stock | 59.801 | $10.72 | $641.18 |
DisclosureSEC source: 0001773229-20-000023 · primary_doc.xml · nonDerivative · entry 5 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,908.049 F1 · security: Reflects 322.068 shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 12:33 UTC |
NICHOLS ROY JDirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000011 · primary_doc.xml · derivative · entry 1 NICHOLS ROY J · CIK 0000937725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 17:22 UTC |
Walker Kathryn ADirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000017 · primary_doc.xml · derivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each divided equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each divided equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each divided equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 17:16 UTC |
HUSS H FENWICKDirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000016 · primary_doc.xml · derivative · entry 1 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 17:11 UTC |
McCray Gregory JamesDirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000015 · primary_doc.xml · derivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 17:04 UTC |
Jacqueline Hourigan RiceDirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000014 · primary_doc.xml · derivative · entry 1 Jacqueline Hourigan Rice · CIK 0001637150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:57 UTC |
Melone Anthony J.Director
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000013 · primary_doc.xml · derivative · entry 1 Melone Anthony J. · CIK 0001507363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:51 UTC |
Nair BalanDirector
|
GrantDividend Equivalent Rights · Derivative | 70.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000012 · primary_doc.xml · derivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167.993 Underlying: Common Stock · 70.691 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC |
Foliano MichaelCFO & Senior Vice President
|
GrantPhantom Stock · Derivative | 139.14 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000010 · primary_doc.xml · derivative · entry 1 Foliano Michael · CIK 0001300513 · CFO & Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,743.15 Underlying: Common Stock · 139.14 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:10 UTC |
Wilson James Denson JrSenior Vice President
|
GrantPhantom Stock · Derivative | 162.43 | $0.00 | $0.00 |
DisclosureSEC source: 0001773229-19-000009 · primary_doc.xml · derivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,086.26 Underlying: Common Stock · 162.43 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.